Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
business development
Biotech
Geopolitics threatens Chinese biotechs' hot out-licensing biz
For the first time, China biotechs out-licensed more assets in 2023 than they in-licensed.
Max Bayer
Apr 11, 2024 4:00am
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
Biogen's top dealmaker is keen on rare disease meds
Mar 5, 2024 10:20am
Astellas bets more than $800M on Kelonia's delivery tech
Feb 15, 2024 6:30pm
J&J sees ‘opportunities’ in neuro and immunology post-Ambrx buy
Jan 23, 2024 10:54am
Sanofi CEO does not rule out future Pompe BD despite FTC moves
Jan 10, 2024 3:37pm